Darifenacin, an M3 selective receptor antagonist, reduces the frequency of nocturnal awakening, an important symptom of overactive bladder

被引：5
|
作者：
Khullar, V
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)37753-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [21] COMPARISON OF EFFICACY AND TOLERABILITY OF TWO SELECTIVE M3 RECEPTOR ANTAGONISTS SOLIFENACIN AND DARIFENACIN IN WOMEN WITH OVERACTIVE BLADDER - THE SOLIDAR STUDY
    But, I
    Pakiz, M.
    Hlebic, G.
    Poteko, S.
    Rozic, N.
    Venier, B.
    NEUROUROLOGY AND URODYNAMICS, 2010, 29 (06) : 1217 - 1219
  • [22] Efficacy, tolerability and safety of darifenacin, an M3 selective receptor antagonist:: an investigation of warning time in patients with OAB
    Zinner, N
    Susset, J
    Gittelman, M
    Arguinzoniz, M
    Rekeda, L
    Haab, F
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (01) : 119 - 126
  • [23] In vivo profile of darifenacin, a selective muscarinic M(3) receptor antagonist
    Quinn, P
    McIntyre, P
    Miner, WD
    Wallis, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P198 - P198
  • [24] An investigation of dose titration with darifenacin, an M3-selective receptor antagonist
    Steers, W
    Corcos, J
    Foote, J
    Kralidis, G
    BJU INTERNATIONAL, 2005, 95 (04) : 580 - 586
  • [25] The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function
    Golding, John F.
    Wesnes, Keith A.
    Leaker, Brian R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (07) : 1535 - 1543
  • [26] Discovery of a muscarinic M3 receptor selective antagonist.
    Ohtake, N
    Sagara, Y
    Kimura, T
    Fujikawa, T
    Hirose, H
    Hasegawa, T
    Noguchi, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U233 - U233
  • [27] An oral selective M3 cholinergic receptor antagonist in COPD
    Lu, S.
    Parekh, D. D.
    Kuznetsova, O.
    Green, S. A.
    Tozzi, C. A.
    Reiss, T. F.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (04) : 772 - 780
  • [28] In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder
    Salcedo, C.
    Davalillo, S.
    Cabellos, J.
    Lagunas, C.
    Balsa, D.
    Perez-del-Pulgar, S.
    Ballarin, M.
    Fernandez, A. G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 156 (05) : 807 - 817
  • [29] Efficacy, tolerability and safety of darifenacin, an M3 selective receptor antagonist:: an investigation of warning time in patients with OAB (vol 60, pg 119, 2006)
    Zinner, N.
    Susset, J.
    Gittelman, M.
    Arguinzoniz, M.
    Rekeda, L.
    Haab, F.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (07) : 890 - 890
  • [30] Cyclohexylmethylpiperidinyltriphenylpropioamide:: A selective muscarinic M3 antagonist discriminating against the other receptor subtypes
    Sagara, Y
    Sagara, T
    Mase, T
    Kimura, T
    Numazawa, T
    Fujikawa, T
    Noguchi, K
    Ohtake, N
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) : 984 - 987
12345